MedTrace Logo

Monoamine Transporter Function and Autonomic Regulation During Psychodynamic Psychotherapy

NCT00594711 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2011-10-31

No results posted yet for this study

Summary

Outcome of psychodynamic psychotherapy measured by \[123I\] nor-B-CIT SPET imaging

Background Psychodynamic psychotherapy is a widely practised form of psychotherapy in the treatment of depression. There is evidence that serotonin transporter (SERT) densities are altered in depression. Preliminary observations have suggested that SERT function may recover in connection with dynamic psychotherapy.

The objective was to determine whether SERT densities change in relation to clinical recovery during psychodynamic psychotherapy.

Conditions

Sponsors & Collaborators

  • University of Eastern Finland

    collaborator OTHER

  • Kuopio University Hospital

    lead OTHER

Principal Investigators

  • Pirjo Saarinen, Ph.D. · Kuopio University Hospital

  • Johannes Lehtonen, Ph.D · Kuopio University Hospital

  • Lehto Soili, MD · Kuopio University Hospital

  • Minna Valkonen-Korhonen, Ph.D · Kuopio University

  • Pasi Ahola, MD · Kuopio University

  • Mikko Joensuu, MD · Kuopio University Hospital

  • Tommi Tolmunen, Ph.D. · Kuopio University Hospital

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-01-31
Completion
2008-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00594711 on ClinicalTrials.gov